Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28,301,887
-
Total 13F shares
-
218,008
-
Share change
-
+26,839
-
Total reported value
-
$1,367,590
-
Price per share
-
$6.28
-
Number of holders
-
21
-
Value change
-
+$1,323,891
-
Number of buys
-
18
-
Number of sells
-
1
Institutional Holders of T2 Biosystems, Inc. - Common Stock, par value $0.001 per share (TTOO) as of Q4 2023
As of 31 Dec 2023,
T2 Biosystems, Inc. - Common Stock, par value $0.001 per share (TTOO) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
218,008 shares.
The largest 10 holders included
SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, JANE STREET GROUP, LLC, Virtu Financial LLC, GROUP ONE TRADING, L.P., OSAIC HOLDINGS, INC., and Tower Research Capital LLC (TRC).
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.